Artera Unveils Four Presentations at ASTRO 2025 Illustrating its Multimodal Artificial Intelligence (MMAI) Platform’s Scalability, Speed, and Potential to Personalize ...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will present four abstracts at the 2025 American Society for Radiation Oncology Annual ...
Mid-Day

Advancing Ethical Frontiers in Artificial Intelligence: The Work of Sai Srujana Buddi in Multimodal and Responsible AI

Researcher Sai Srujana Buddi leads efforts in responsible AI, building safety and ethical frameworks for generative and ...

Candel Therapeutics to Present at the SITC 2025 Annual Meeting

Title: Integrative discovery of a multimodal cancer immunotherapy using machine learning and viral vector engineering Presenter : Anne Diers, Ph.D., Vice President, Research, Candel Therapeutics ...
UroToday

ASTRO 2025: Validation of a Prognostic Multimodal Artificial Intelligence Model in Asian Prostate Cancer Patients from Singapore

(UroToday.com) The 2025 ASTRO annual meeting featured a predictive markers in prostate cancer session and a presentation by Dr. Melvin L. K. Chua discussing validation of a prognostic multimodal ...

Allergan Aesthetics to Showcase Multimodal Treatment Approach and Continued Commitment to Skin Quality at AMWC Dubai

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is set to present comprehensive AA Signature™ multimodal treatment approach to global audience, at the upcoming Internationally recognized ...